loadpatents
name:-0.022490978240967
name:-0.014798879623413
name:-0.00050497055053711
SEBHAT; Iyassu Patent Filings

SEBHAT; Iyassu

Patent Applications and Registrations

Patent applications and USPTO patent grants for SEBHAT; Iyassu.The latest application filed is for "gpr40 agonists".

Company Profile
0.19.23
  • SEBHAT; Iyassu - Jersey City NJ
  • SEBHAT; Iyassu - Shanghai US
  • SEBHAT; Iyassu - US
  • Sebhat, Iyassu - Hoboken NJ
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Gpr40 Agonists
App 20220289772 - SEBHAT; Iyassu ;   et al.
2022-09-15
AMPK activators
Grant 11,407,768 - Sebhat , et al. August 9, 2
2022-08-09
Ampk Activators
App 20220227754 - SEBHAT; Iyassu ;   et al.
2022-07-21
Gpr40 Agonists
App 20220226298 - SEBHAT; Iyassu ;   et al.
2022-07-21
Gpr119 Agonists
App 20220153719 - SEBHAT; Iyassu ;   et al.
2022-05-19
Gpcr Combination Therapies
App 20220152164 - THORNBERRY; Nancy ;   et al.
2022-05-19
Ampk Activators
App 20220033401 - SEBHAT; Iyassu ;   et al.
2022-02-03
Ampk Activators
App 20220002317 - SEBHAT; Iyassu ;   et al.
2022-01-06
Azabenzimidazole tetrahydrofuran derivatives
Grant 9,868,733 - Apgar , et al. January 16, 2
2018-01-16
Indole derivatives useful as anti-diabetic agents
Grant 9,650,375 - Acton, III , et al. May 16, 2
2017-05-16
Benzimidazole hexahydrofuro[3,2-b]furan derivatives
Grant 9,556,193 - Apgar , et al. January 31, 2
2017-01-31
Benzimidazole tetrahydrofuran derivatives
Grant 9,540,364 - Apgar , et al. January 10, 2
2017-01-10
Benzimidazole tetrahydropyran derivatives
Grant 9,527,839 - Apgar , et al. December 27, 2
2016-12-27
Azabenzimidazole tetrahydropyran derivatives
Grant 9,382,243 - Apgar , et al. July 5, 2
2016-07-05
Azabenzimidazole hexahydrofuro[3,2-b]furan derivatives
Grant 9,290,517 - Apgar , et al. March 22, 2
2016-03-22
Novel Indole Derivatives Useful As Anti-diabetic Agents
App 20160002224 - Acton, III; John J. ;   et al.
2016-01-07
Novel Azabenzimidazole Hexahydrofuro[e,2-b]furan Derivatives
App 20150284411 - Apgar; James M. ;   et al.
2015-10-08
Novel Benzimidazole Tetrahydrofuran Derivatives
App 20150218149 - Apgar; James M. ;   et al.
2015-08-06
Novel Benzimidazole Hexahydrofuro[3,2-b]furan Derivatives
App 20150218183 - Apgar; James M. ;   et al.
2015-08-06
Novel Azabenzimidazole Tetrahydropyran Derivatives
App 20150210685 - Apgar; James M. ;   et al.
2015-07-30
Novel Azabenzimidazole Tetrahydrofuran Derivatives
App 20150203487 - Apgar; James M. ;   et al.
2015-07-23
Novel Benzimidazole Tetrahydropyran Derivatives
App 20150197516 - Apgar; James M. ;   et al.
2015-07-16
Cyclic azabenzimidazole derivatives useful as anti-diabetic agents
Grant 8,796,258 - Anand , et al. August 5, 2
2014-08-05
Cyclic benzimidazole derivatives useful as anti-diabetic agents
Grant 8,563,746 - Dang , et al. October 22, 2
2013-10-22
Novel Cyclic Azabenzimidazole Derivatives Useful As Anti-diabetic Agents
App 20130123237 - Anand; Rajan ;   et al.
2013-05-16
Cyclic benzimidazole derivatives useful as anti-diabetic agents
Grant 8,410,284 - Dang , et al. April 2, 2
2013-04-02
Cyclic benzimidazole derivatives useful as anti-diabetic agents
Grant 8,394,969 - Bookser , et al. March 12, 2
2013-03-12
Cyclic benzimidazole derivatives useful as anti-diabetic agents
Grant 8,329,914 - Bao , et al. December 11, 2
2012-12-11
Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents
App 20110263533 - Dang; Qun ;   et al.
2011-10-27
Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents
App 20110218174 - Bao; Jianming ;   et al.
2011-09-08
Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents
App 20110195964 - Dang; Qun ;   et al.
2011-08-11
Novel Cyclic Benzimidazole Derivatives Useful As Anti-diabetic Agents
App 20100081643 - BOOKSER; BRETT C. ;   et al.
2010-04-01
Substituted piperidines as melanocortin-4 receptor agonists
App 20020137664 - Bakshi, Raman K. ;   et al.
2002-09-26
Substituted piperidines as melanocortin-4 receptor agonists
Grant 6,350,760 - Bakshi , et al. February 26, 2
2002-02-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed